Predictors of response to infliximab in patients with fistulizing Crohn's disease Factores predictivos de respuesta a infliximab en pacientes con enfermedad de Crohn fistulizante

Objective: to evaluate the efficacy and toxicity of infliximab for the treatment of fistulizing Crohn's disease. Methods: consecutive patients with fistulizing Crohn's disease receiving infliximab were prospectively enrolled. Partial response was defined as a reduction of 50% or more from...

Full description

Bibliographic Details
Main Authors: M. Luna-Chadid, J.L. Pérez Calle, J.L. Mendoza, M. I. Vera, A. F. Bermejo, F. Sánchez, A. López San Román, C. Froilán, V. González-Lara, J. García-Paredes, I. Fernández-Blanco, L. Abreu, B. Casis, J. A. Solís Herruzo, J.P. Gisbert, J. Maté-Jiménez
Format: Article
Language:English
Published: Aran Ediciones 2004-06-01
Series:Revista Espanola de Enfermedades Digestivas
Subjects:
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082004000600003